Physician profile
Ian P Ford
NPI 1235321118
$909.31
in general payments reported to CMS, 2019-2025
15 companies · $76.53 in 2025
The $76.53 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.30 · 2020: $17.89 · 2021: $62.00 · 2022: $143 · 2023: $276 · 2024: $275 · 2025: $76.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565 · Education: $35.68 · Entertainment: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.80 |
| Education | $35.68 |
| Entertainment | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $319.47 | 2019-2025 | Clareon, Dailies Total1 |
| Bausch & Lomb Americas INC. | $195.43 | 2023-2025 | Miebo, Xiidra, Infuse |
| Tarsus Pharmaceuticals, INC. | $60.58 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $55.58 | 2022-2023 | Cequa |
| Oyster Point Pharma, INC. | $44.08 | 2023-2024 | Tyrvaya |
| Abbvie INC. | $41.73 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $28.72 | 2022 | |
| Coopervision INC. | $27.82 | 2023 | Myday Contact Lens |
| Allergan, INC. | $27.72 | 2021 | |
| Optos, INC. | $26.70 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $18.63 | 2023 | |
| Quidel Corporation | $18.18 | 2022 | |
| Sight Sciences, INC. | $17.83 | 2022 | |
| Shire North American Group INC | $15.69 | 2019 | |
| Aerie Pharmaceuticals, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.